BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15356121)

  • 1. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement.
    Fallarino F; Asselin-Paturel C; Vacca C; Bianchi R; Gizzi S; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P
    J Immunol; 2004 Sep; 173(6):3748-54. PubMed ID: 15356121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.
    Fallarino F; Orabona C; Vacca C; Bianchi R; Gizzi S; Asselin-Paturel C; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P
    Int Immunol; 2005 Nov; 17(11):1429-38. PubMed ID: 16172135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.
    Puccetti P; Fallarino F
    Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
    Munn DH; Sharma MD; Mellor AL
    J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor.
    Hatherley D; Cherwinski HM; Moshref M; Barclay AN
    J Immunol; 2005 Aug; 175(4):2469-74. PubMed ID: 16081818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.
    Belladonna ML; Grohmann U; Guidetti P; Volpi C; Bianchi R; Fioretti MC; Schwarcz R; Fallarino F; Puccetti P
    J Immunol; 2006 Jul; 177(1):130-7. PubMed ID: 16785507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.
    Rygiel TP; Karnam G; Goverse G; van der Marel AP; Greuter MJ; van Schaarenburg RA; Visser WF; Brenkman AB; Molenaar R; Hoek RM; Mebius RE; Meyaard L
    Oncogene; 2012 Jun; 31(24):2979-88. PubMed ID: 22020332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
    Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant.
    Orabona C; Belladonna ML; Vacca C; Bianchi R; Fallarino F; Volpi C; Gizzi S; Fioretti MC; Grohmann U; Puccetti P
    J Immunol; 2005 Jun; 174(11):6582-6. PubMed ID: 15905495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of myeloid receptor expression and interferon alpha/beta production in murine plasmacytoid dendritic cells by flow cytomtery.
    Seeds RE; Gordon S; Miller JL
    J Immunol Methods; 2009 Oct; 350(1-2):106-17. PubMed ID: 19666024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy.
    Darmochwal-Kolarz DA; Kludka-Sternik M; Chmielewski T; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    Am J Reprod Immunol; 2012 Jun; 67(6):474-81. PubMed ID: 22462561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
    Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
    Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.
    Munn DH; Sharma MD; Hou D; Baban B; Lee JR; Antonia SJ; Messina JL; Chandler P; Koni PA; Mellor AL
    J Clin Invest; 2004 Jul; 114(2):280-90. PubMed ID: 15254595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
    Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
    J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.
    Fallarino F; Gizzi S; Mosci P; Grohmann U; Puccetti P
    Curr Drug Metab; 2007 Apr; 8(3):209-16. PubMed ID: 17430109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
    Fallarino F; Grohmann U; Puccetti P
    Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
    Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
    Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.
    Grohmann U; Bianchi R; Orabona C; Fallarino F; Vacca C; Micheletti A; Fioretti MC; Puccetti P
    J Immunol; 2003 Sep; 171(5):2581-7. PubMed ID: 12928409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
    Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.